LS BIOPATH, INC. — Form D
LS BIOPATH, INC. of Saratoga, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-06. The offering totals $8.0M, of which $6.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-06
- Form: D
- Accession: 0001477519-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $6.9M
- Remaining: $1.1M
- Investors: 51
- Date of first sale: 2021-06-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-405327
Issuer
- Name: LS BIOPATH, INC.
- CIK: 0001477519
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 18809 Cox Avenue, Saratoga, CA, 95070
- Phone: 408-963-6352
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Rusmin Kudinar | Director | Emeryville, CA |
| Jim Pfeiffer | Director | Saratoga, CA |
| Moshe Sarfaty | Director | Saratoga, CA |
| Moshe Sarfaty | Executive Officer | Saratoga, CA |
| AMIR LEV | Director | MOUNTAIN VIEW, CA |
| AMIR LEV | Executive Officer | MOUNTAIN VIEW, CA |
Other filings by this issuer (2)
More